0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Central Precocious Puberty (CPP) Treatment Market Report 2025 - Product Thumbnail Image

Central Precocious Puberty (CPP) Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Calcium Phosphate Cement Market Report 2025 - Product Thumbnail Image

Calcium Phosphate Cement Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Gouty Arthritis Market Report 2025 - Product Thumbnail Image

Gouty Arthritis Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Semaglutides Market Report 2025 - Product Thumbnail Image

Semaglutides Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Calcium Gluconate Market Report 2025 - Product Thumbnail Image

Calcium Gluconate Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Fabry Disease Treatment Market Report 2025 - Product Thumbnail Image

Fabry Disease Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Bioidentical Hormones Market Report 2025 - Product Thumbnail Image

Bioidentical Hormones Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,490USDGBP
Dulaglutide Market Report 2025 - Product Thumbnail Image

Dulaglutide Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Combined Pituitary Hormone Deficiencies Market Report 2025 - Product Thumbnail Image

Combined Pituitary Hormone Deficiencies Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Liraglutide and Semaglutide Market Report 2025 - Product Thumbnail Image

Liraglutide and Semaglutide Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Liraglutide Market Report 2025 - Product Thumbnail Image

Liraglutide Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Human Chorionic Gonadotropin Market Report 2025 - Product Thumbnail Image

Human Chorionic Gonadotropin Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Lipid Disorder Treatment Market Report 2025 - Product Thumbnail Image

Lipid Disorder Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Human Growth Hormone Market Report 2025 - Product Thumbnail Image

Human Growth Hormone Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Non-Insulin Therapies for Diabetes Market Report 2025 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Metformin Market Report 2025 - Product Thumbnail Image

Metformin Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Levothyroxine Sodium Market Report 2025 - Product Thumbnail Image

Levothyroxine Sodium Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,490USDGBP
Antidiabetics Market Report 2025 - Product Thumbnail Image

Antidiabetics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more